Xilio Therapeutics Inc. (XLO)
NASDAQ: XLO
· Real-Time Price · USD
0.77
0.02 (1.99%)
At close: May 02, 2025, 2:17 PM
13F Institute Ownership
Total Institutes of 35 in Xilio Therapeutics expanded their positions with an increase of 2 investors compared to the previous quarter. An additional 9.9M shares, as total invested capital grew by $12.11M with ownership percentage increasing from 25.14% to 40.74%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 14.35% | 9.11M | +100.00% | 8.7M | 0.56% |
| Bain Capital Life Sciences Inv... | 7.20% | 4.57M | +0.00% | 4.36M | 0.51% |
| Rock Springs Capital Managemen... | 4.73% | 3M | +0.00% | 2.87M | 0.11% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.